| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019616486 |
| P356 | DOI | 10.1038/NRM3448 |
| P698 | PubMed publication ID | 23034453 |
| P5875 | ResearchGate publication ID | 232008928 |
| P50 | author | Fred Gage | Q895547 |
| Milena Bellin | Q54478428 | ||
| Maria C Marchetto | Q91395511 | ||
| Christine Mummery | Q28842449 | ||
| P2860 | cites work | Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology | Q21134989 |
| LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress | Q24294466 | ||
| Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells | Q24300095 | ||
| Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients | Q24595997 | ||
| Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells | Q24617599 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview | Q24618089 | ||
| Modelling schizophrenia using human induced pluripotent stem cells | Q24633007 | ||
| Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells | Q24634829 | ||
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors | Q27438004 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| The International HapMap Project | Q27860695 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| A TALE nuclease architecture for efficient genome editing | Q28301656 | ||
| Generation of pluripotent stem cells from patients with type 1 diabetes | Q37327472 | ||
| Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 | ||
| Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation | Q37734466 | ||
| Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models | Q37832530 | ||
| Methods for making induced pluripotent stem cells: reprogramming à la carte | Q37845645 | ||
| Strategies for homeostatic stem cell self-renewal in adult tissues | Q37887870 | ||
| Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development | Q37894263 | ||
| Diseases in a dish: modeling human genetic disorders using induced pluripotent cells | Q37965334 | ||
| Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells | Q38462208 | ||
| Conversion of mouse and human fibroblasts into functional spinal motor neurons | Q38651033 | ||
| Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. | Q38771932 | ||
| Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease | Q39339606 | ||
| The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity | Q39382468 | ||
| Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations | Q39506695 | ||
| Disease characterization using LQTS-specific induced pluripotent stem cells | Q39595974 | ||
| Complete genetic correction of ips cells from Duchenne muscular dystrophy | Q39641162 | ||
| Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells | Q39673715 | ||
| Generation of human embryonic stem cell reporter lines expressing GFP specifically in neural progenitors | Q39699814 | ||
| Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin | Q39748845 | ||
| Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes | Q39759039 | ||
| Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells | Q39910905 | ||
| Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells | Q39971906 | ||
| Marked differences in differentiation propensity among human embryonic stem cell lines | Q40012772 | ||
| A method for genetic modification of human embryonic stem cells using electroporation | Q40143374 | ||
| Identification and selection of cardiomyocytes during human embryonic stem cell differentiation | Q40145603 | ||
| Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells | Q40648427 | ||
| Preparation of uniaxial multichannel silk fibroin scaffolds for guiding primary neurons. | Q42013709 | ||
| IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients | Q42049161 | ||
| Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. | Q42118625 | ||
| A targeted NKX2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives. | Q42485666 | ||
| Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency | Q42811272 | ||
| Restricted ethnic diversity in human embryonic stem cell lines | Q42812882 | ||
| Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells | Q42814864 | ||
| A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects | Q42815540 | ||
| Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients | Q42817044 | ||
| Modeling familial Alzheimer's disease with induced pluripotent stem cells | Q42817521 | ||
| Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification | Q42817633 | ||
| Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease | Q42818202 | ||
| Drug screening for ALS using patient-specific induced pluripotent stem cells | Q42820289 | ||
| Vitamin C enhances the generation of mouse and human induced pluripotent stem cells | Q43207059 | ||
| Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart | Q44364053 | ||
| 2011 FDA drug approvals | Q44973933 | ||
| Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells | Q47788549 | ||
| Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient | Q48860052 | ||
| Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. | Q49153656 | ||
| CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. | Q50305506 | ||
| Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. | Q50506853 | ||
| NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. | Q50509476 | ||
| Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. | Q51511217 | ||
| Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing. | Q54785499 | ||
| The dark side of induced pluripotency | Q59048452 | ||
| High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity | Q59696431 | ||
| Stem cells. Diseases in a dish take off | Q82616931 | ||
| Induced pluripotent stem cells--a cautionary note | Q84242212 | ||
| Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes | Q85250707 | ||
| Erosion of dosage compensation impacts human iPSC disease modeling | Q36703082 | ||
| In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells | Q37005193 | ||
| SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. | Q37104201 | ||
| Reprogramming of human primary somatic cells by OCT4 and chemical compounds | Q37267824 | ||
| Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation | Q37294805 | ||
| Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells | Q28475963 | ||
| Modeling retinal degeneration using patient-specific induced pluripotent stem cells | Q28477132 | ||
| Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model | Q28477225 | ||
| Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 | ||
| Induced pluripotent stem cells generated without viral integration | Q29614343 | ||
| Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease | Q29615682 | ||
| Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells | Q29615870 | ||
| Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 | ||
| Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population | Q29616533 | ||
| Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 | ||
| Somatic coding mutations in human induced pluripotent stem cells | Q29616798 | ||
| Pre-mRNA splicing and human disease | Q29617335 | ||
| Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development | Q29617978 | ||
| Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Modelling the long QT syndrome with induced pluripotent stem cells | Q29620092 | ||
| Patient-specific induced pluripotent stem-cell models for long-QT syndrome | Q29620353 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Development of functional human embryonic stem cell-derived neurons in mouse brain | Q30476562 | ||
| Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome | Q30499663 | ||
| Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome | Q30529349 | ||
| Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. | Q30539904 | ||
| Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses | Q30562410 | ||
| Transcriptional signature and memory retention of human-induced pluripotent stem cells | Q33504601 | ||
| Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders | Q33560423 | ||
| Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. | Q33672762 | ||
| Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency | Q33732735 | ||
| Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome | Q33910479 | ||
| Engineering of human pluripotent stem cells by AAV-mediated gene targeting | Q33930075 | ||
| Reprogramming of mouse and human cells to pluripotency using mature microRNAs. | Q34027071 | ||
| Transgene-free production of pluripotent stem cells using piggyBac transposons | Q34028014 | ||
| Transgene excision has no impact on in vivo integration of human iPS derived neural precursors | Q34035837 | ||
| Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia | Q34051160 | ||
| Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats | Q34115609 | ||
| Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa | Q34120479 | ||
| Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. | Q34175757 | ||
| Harnessing the potential of induced pluripotent stem cells for regenerative medicine | Q34182222 | ||
| Induced pluripotency: history, mechanisms, and applications | Q34206028 | ||
| High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. | Q34213428 | ||
| Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming | Q34245487 | ||
| The promise of induced pluripotent stem cells in research and therapy | Q34248218 | ||
| Diagnosing the decline in pharmaceutical R&D efficiency | Q34257771 | ||
| Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions | Q34373911 | ||
| Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome) | Q34557967 | ||
| L1 retrotransposition in neurons is modulated by MeCP2 | Q34686579 | ||
| Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines | Q34714112 | ||
| Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation | Q34793218 | ||
| Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome | Q34930935 | ||
| Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation | Q34955419 | ||
| Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. | Q35008203 | ||
| Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting | Q35030912 | ||
| Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C | Q35052074 | ||
| Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients | Q35175041 | ||
| Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia | Q35291933 | ||
| Specification of neuronal and glial subtypes from human pluripotent stem cells | Q35501624 | ||
| Nanowired three-dimensional cardiac patches | Q35528919 | ||
| A functionally characterized test set of human induced pluripotent stem cells | Q35588556 | ||
| Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy | Q35612944 | ||
| Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus | Q35692589 | ||
| Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility | Q35737818 | ||
| Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture | Q35794574 | ||
| Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model | Q35809643 | ||
| Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability | Q35889309 | ||
| Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells | Q35947171 | ||
| Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells | Q35966957 | ||
| Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia | Q36037969 | ||
| Signaling defects in iPSC-derived fragile X premutation neurons | Q36142068 | ||
| Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome | Q36142076 | ||
| Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs | Q36345932 | ||
| P433 | issue | 11 | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 713-726 | |
| P577 | publication date | 2012-10-04 | |
| P1433 | published in | Nature Reviews Molecular Cell Biology | Q1573120 |
| P1476 | title | Induced pluripotent stem cells: the new patient? | |
| P478 | volume | 13 |
| Q90461902 | 3D Bioprinted Human Cortical Neural Constructs Derived from Induced Pluripotent Stem Cells |
| Q91786622 | 3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications |
| Q33730154 | 3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells |
| Q50329951 | A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders |
| Q35999782 | A Perspective on Studying G-Protein-Coupled Receptor Signaling with Resonance Energy Transfer Biosensors in Living Organisms |
| Q36740391 | A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies |
| Q37228986 | A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells |
| Q33768227 | A novel mutation in LRSAM1 causes axonal Charcot-Marie-Tooth disease with dominant inheritance |
| Q38573829 | A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies |
| Q39380660 | A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. |
| Q57048812 | A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation |
| Q50518321 | ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. |
| Q33946049 | Abnormal oxidative stress responses in fibroblasts from preeclampsia infants |
| Q33737156 | Adult hair follicle stem cells do not retain the older DNA strands in vivo during normal tissue homeostasis |
| Q38437316 | Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon? |
| Q52606323 | Advanced maturation of human cardiac tissue grown from pluripotent stem cells. |
| Q40786353 | All-optical control of cardiac excitation: combined high-resolution optogenetic actuation and optical mapping |
| Q35595728 | Autism spectrum disorders: emerging mechanisms and mechanism-based treatment. |
| Q38642565 | Back and forth in time: Directing age in iPSC-derived lineages. |
| Q38300878 | Bacterial-induced cell reprogramming to stem cell-like cells: new premise in host-pathogen interactions |
| Q30358385 | Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing |
| Q46303600 | Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface |
| Q101216809 | BrainPhys neuronal medium optimized for imaging and optogenetics in vitro |
| Q30354544 | Bridging the gap between genetic associations and molecular mechanisms for type 2 diabetes. |
| Q40453067 | Capturing the biology of disease severity in a PSC-based model of familial dysautonomia |
| Q28079057 | Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells |
| Q38393181 | Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes |
| Q21195758 | Cardiac regeneration and diabetes |
| Q34534994 | Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cells |
| Q48143410 | Comparative transcriptomics of hepatic differentiation of human pluripotent stem cells and adult human liver tissue. |
| Q36958208 | Complexity of dopamine metabolism. |
| Q56879461 | Comprehensive comparative analysis of 5'-end RNA-sequencing methods |
| Q28080945 | Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology |
| Q38850545 | Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease |
| Q28649438 | Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration |
| Q41788686 | Convergent functional genomics of stem cell-derived cells |
| Q38997127 | Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2. |
| Q55260762 | Current state of therapeutic development for rare cancers in Japan, and proposals for improvement. |
| Q39301532 | Deep intronic mutations and human disease |
| Q37017090 | Derivation of Diverse Hormone-Releasing Pituitary Cells from Human Pluripotent Stem Cells. |
| Q38257522 | Design strategies of biodegradable scaffolds for tissue regeneration |
| Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
| Q40311122 | Differentiation of human and murine induced pluripotent stem cells to microglia-like cells |
| Q58734825 | Differentiation of human iPSCs into functional podocytes |
| Q38911795 | Differentiation of human pluripotent stem cells into Medial Ganglionic Eminence vs. Caudal Ganglionic Eminence cells |
| Q38883549 | Differentiation of neuroepithelial stem cells into functional dopaminergic neurons in 3D microfluidic cell culture |
| Q37619231 | Disease models for the development of therapies for lysosomal storage diseases |
| Q52975832 | Dynamic Variations in Genetic Integrity Accompany Changes in Cell Fate. |
| Q35665070 | Effectiveness of gene delivery systems for pluripotent and differentiated cells. |
| Q40982138 | Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus |
| Q35010413 | Efficient production of retroviruses using PLGA/bPEI-DNA nanoparticles and application for reprogramming somatic cells |
| Q38440243 | Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation. |
| Q42060920 | Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells |
| Q38750884 | Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs) |
| Q47207619 | Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes |
| Q38378499 | Engineering Stem Cells for Biomedical Applications. |
| Q58556060 | Epigenetic Control of Endocrine Pancreas Differentiation : Current Knowledge and Future Perspectives |
| Q35699296 | Epigenetic changes in the developing brain: Effects on behavior |
| Q35180607 | Epigenetic therapy for Friedreich ataxia |
| Q26781319 | Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes |
| Q91678555 | Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking |
| Q38207606 | Familial Alzheimer's disease modelling using induced pluripotent stem cell technology |
| Q91802461 | Fast and Efficient Neural Conversion of Human Hematopoietic Cells |
| Q34684538 | Fast and efficient neural conversion of human hematopoietic cells |
| Q39060361 | Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells. |
| Q37592348 | Functional roles of Nurr1, Pitx3, and Lmx1a in neurogenesis and phenotype specification of dopamine neurons during in vitro differentiation of embryonic stem cells |
| Q26849397 | Functions of heterogeneous nuclear ribonucleoproteins in stem cell potency and differentiation |
| Q33552001 | Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment |
| Q27333621 | Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells |
| Q27301480 | Generation of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring Contractility |
| Q35162006 | Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells |
| Q28544903 | Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse |
| Q92823561 | Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (I K,ACh) |
| Q26996283 | Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease |
| Q44315676 | Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction |
| Q40637296 | Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1. |
| Q97529091 | Human forebrain endothelial cell therapy for psychiatric disorders |
| Q39345477 | Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. |
| Q41609643 | Human iPS cell models of Jervell and Lange-Nielsen syndrome |
| Q41868474 | Human iPSC-based modeling of late-onset disease via progerin-induced aging |
| Q55194774 | Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy. |
| Q38643034 | Human induced pluripotent stem cells as a research tool in Alzheimer's disease |
| Q41664792 | Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies |
| Q90599546 | Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease |
| Q38136473 | In vivo reprogramming in inflammatory bowel disease |
| Q38559734 | Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead. |
| Q38116769 | Induced Pluripotent Stem Cells and Disorders of the Nervous System: Progress, Problems, and Prospects |
| Q38242113 | Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases |
| Q38104143 | Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling |
| Q38218254 | Induced pluripotent stem cells for regenerative medicine |
| Q26749360 | Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy |
| Q34036938 | Induced pluripotent stem cells in medicine and biology |
| Q92512243 | Induced pluripotent stem cells, a giant leap for mankind therapeutic applications |
| Q28079217 | Inherited heart disease - what can we expect from the second decade of human iPS cell research? |
| Q38819976 | Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? |
| Q38182329 | Integrating the roles of long and small non-coding RNA in brain function and disease |
| Q90482640 | Intensive care for human hearts in pluripotent stem cell models |
| Q38130450 | Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells |
| Q34038853 | Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome |
| Q35781992 | Large-Scale Nanoelectrode Arrays to Monitor the Dopaminergic Differentiation of Human Neural Stem Cells |
| Q28829869 | Large-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture System |
| Q36239384 | Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research |
| Q50210670 | Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells |
| Q64075653 | MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo |
| Q47241525 | MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo. |
| Q34153953 | Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts |
| Q26852506 | Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair |
| Q34341540 | MiRiad Roles for MicroRNAs in Cardiac Development and Regeneration |
| Q26747691 | Microfluidic organ-on-chip technology for blood-brain barrier research |
| Q36600856 | Micropost arrays for measuring stem cell-derived cardiomyocyte contractility |
| Q89741244 | Migration, Chemo-Attraction, and Co-Culture Assays for Human Stem Cell-Derived Endothelial Cells and GABAergic Neurons |
| Q26748486 | Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges |
| Q26799933 | Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems |
| Q34540416 | Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity |
| Q35056065 | Modeling human neurological disorders with induced pluripotent stem cells |
| Q39130188 | Modeling neurodevelopmental and psychiatric diseases with human iPSCs |
| Q51043236 | Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. |
| Q37609839 | Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells |
| Q38248400 | Molecular networks and the evolution of human cognitive specializations |
| Q33861723 | Monitoring the differentiation and migration patterns of neural cells derived from human embryonic stem cells using a microfluidic culture system. |
| Q37622098 | Multiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells. |
| Q40884175 | Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis |
| Q38110960 | Neural stem cells as tools for drug discovery: novel platforms and approaches |
| Q35644670 | Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro |
| Q36568097 | Neuropeptidomics Mass Spectrometry Reveals Signaling Networks Generated by Distinct Protease Pathways in Human Systems |
| Q26995562 | New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism |
| Q38986478 | On the shoulders of Hubrecht: From embryos to stem cells |
| Q37617276 | One-Step Seeding of Neural Stem Cells with Vitronectin-Supplemented Medium for High-Throughput Screening Assays |
| Q63246542 | Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease |
| Q34353458 | Opportunities and challenges of pluripotent stem cell neurodegenerative disease models |
| Q47822920 | Optical Method to Quantify Mechanical Contraction and Calcium Transients of Human Pluripotent Stem Cell-Derived Cardiomyocytes. |
| Q27317028 | OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology. |
| Q38905001 | Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems |
| Q38195304 | Organs-on-a-chip: a new tool for drug discovery |
| Q37693830 | Origins and implications of pluripotent stem cell variability and heterogeneity |
| Q37337917 | Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation |
| Q35600964 | Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons |
| Q51389361 | Patient iPSCs: a new discovery tool for Smith-Lemli-Opitz syndrome. |
| Q39144910 | Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research. |
| Q42962438 | Pluripotent and somatic stem cells: from basic science to utilization in disease modeling and therapeutic application. Meeting report on the 7th International Meeting of the Stem Cell Network North Rhine Westphalia. |
| Q37121491 | Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesis |
| Q38714328 | Pluripotent stem cells in disease modelling and drug discovery |
| Q26999292 | Pluripotent stem cells in regenerative medicine: challenges and recent progress |
| Q37351739 | Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology |
| Q28082747 | Present and future challenges of induced pluripotent stem cells |
| Q27008903 | Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency |
| Q26776053 | Prospects and Challenges of Induced Pluripotent Stem Cells in Equine Health |
| Q40090286 | RNAseq analysis for the diagnosis of muscular dystrophy |
| Q37414577 | Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells. |
| Q41573786 | Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing. |
| Q34752070 | Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue |
| Q99589769 | Reprogramming Urine-Derived Cells using Commercially Available Self-Replicative RNA and a Single Electroporation |
| Q26853155 | Reprogramming cells with synthetic proteins |
| Q28544716 | Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes |
| Q38482062 | Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers |
| Q37653706 | Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs |
| Q52855874 | Scalable Expansion of Pluripotent Stem Cells. |
| Q30251961 | Schizophrenia. |
| Q34511100 | Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells |
| Q38216498 | Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. |
| Q91991322 | Social Isolation Rearing Induces Neuropsychiatric Diseases: Updated Overview |
| Q90229721 | Stem cell-based Lung-on-Chips: The best of both worlds? |
| Q47559391 | Stem cells: from biomedical research towards clinical applications. |
| Q45205312 | Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes |
| Q87681974 | TGF-β Signaling in Control of Cardiovascular Function |
| Q34428986 | The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery |
| Q92815378 | The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases |
| Q39042193 | The Sustained Impact of Model Organisms-in Genetics and Epigenetics |
| Q34386434 | The aging signature: a hallmark of induced pluripotent stem cells? |
| Q38663718 | The ascendance of microphysiological systems to solve the drug testing dilemma |
| Q35765543 | The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine |
| Q58577684 | The effect of rho kinase inhibition on morphological and electrophysiological maturity in iPSC-derived neurons |
| Q38109499 | The potential of stem cell research for the treatment of neuronal damage in glaucoma. |
| Q38834532 | The use of human adipose-derived stem cells based cytotoxicity assay for acute toxicity test. |
| Q39413537 | Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device |
| Q89107012 | Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials |
| Q38174727 | Tissue engineering for plastic surgeons: a primer |
| Q53479362 | Translational strategies and challenges in regenerative medicine. |
| Q35009852 | Two miRNA clusters reveal alternative paths in late-stage reprogramming |
| Q47705950 | Use of a neonatal rat system as a bioincubator to generate adult-like mature cardiomyocytes from human and mouse pluripotent stem cells. |
| Q35020639 | Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening. |
| Q36357156 | Using human induced pluripotent stem cells to model cerebellar disease: hope and hype. |
| Q39873476 | Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities. |
| Q34143269 | Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure |
| Q42671611 | Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem Cells |
| Q37131089 | Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research? |
| Q43601153 | Workshop meeting report Organs-on-Chips: human disease models |
| Q41947844 | hiPS-MSCs differentiation towards fibroblasts on a 3D ECM mimicking scaffold |
Search more.